Published in Transplantation on December 15, 2002
Increased numbers of low-oxygenated pancreatic islets after intraportal islet transplantation. Diabetes (2011) 1.10
Betacellulin inhibits amylase and glucagon production and promotes beta cell differentiation in mouse embryonic pancreas. Diabetologia (2007) 0.88
Tolerance-inducing strategies in islet transplantation. Int J Endocrinol (2012) 0.80
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
The global obesity pandemic: shaped by global drivers and local environments. Lancet (2011) 13.23
Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med (2007) 6.05
Changing the future of obesity: science, policy, and action. Lancet (2011) 5.56
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology (2010) 3.54
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology (2009) 2.51
Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med (2006) 2.41
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36
Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med (2006) 2.21
A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol (2005) 2.12
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol (2011) 2.12
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2008) 2.04
Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes (2004) 1.98
Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation (2006) 1.89
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A (2009) 1.72
Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes (2002) 1.61
Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass. J Clin Endocrinol Metab (2005) 1.61
Granzyme B: a natural born killer. Immunol Rev (2003) 1.61
Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl (2010) 1.57
Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes (2004) 1.46
A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes (2002) 1.43
Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care (2005) 1.35
Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology (2003) 1.34
Strategic opportunities in clinical islet transplantation. Transplantation (2005) 1.34
beta-cell neogenesis during prolonged hyperglycemia in rats. Diabetes (2002) 1.33
Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes (2002) 1.32
Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Res (2007) 1.31
Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog (2012) 1.29
Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest (2006) 1.28
Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant (2003) 1.26
Portal venous pressure changes after sequential clinical islet transplantation. Transplantation (2002) 1.24
Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int J Parasitol (2006) 1.24
Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab (2004) 1.23
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun (2006) 1.22
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes (2002) 1.20
Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. Cell Transplant (2008) 1.16
TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice. Cancer Res (2004) 1.15
Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant (2007) 1.14
The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit (2005) 1.14
Estimation of pancreas weight from donor variables. Cell Transplant (2006) 1.13
Synaptosome-associated protein of 25 kilodaltons modulates Kv2.1 voltage-dependent K(+) channels in neuroendocrine islet beta-cells through an interaction with the channel N terminus. Mol Endocrinol (2002) 1.13
Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation (2006) 1.12
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes (2005) 1.12
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation (2007) 1.11
Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response. PLoS Pathog (2006) 1.09
A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list. Hepatology (2012) 1.08
Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther (2006) 1.08
The standardization of pancreatic donors for islet isolations. Transplantation (2005) 1.07
m-TOR inhibitors: what role in liver transplantation? J Hepatol (2011) 1.06
Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng (2005) 1.06
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Factors influencing the collagenase digestion phase of human islet isolation. Transplantation (2007) 1.03
Systems science and obesity policy: a novel framework for analyzing and rethinking population-level planning. Am J Public Health (2014) 1.03
Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. Am J Physiol Endocrinol Metab (2007) 1.02
Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res A (2006) 1.01
An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm. Can J Gastroenterol (2010) 1.00
Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Cell Signal (2007) 1.00
Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes (2002) 1.00
Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cells. J Immunol (2006) 1.00
IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant (2003) 0.99
A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice. J Appl Physiol (1985) (2007) 0.98
Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats. Xenotransplantation (2003) 0.98
Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. J Virol Methods (2004) 0.98
Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells. Cell Transplant (2008) 0.98
Cross-sector partnerships and public health: challenges and opportunities for addressing obesity and noncommunicable diseases through engagement with the private sector. Annu Rev Public Health (2015) 0.97
Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol Invest (2003) 0.97
Late acute rejection after liver transplantation: the Western Canada experience. Liver Transpl (2002) 0.96
The place of downstaging for hepatocellular carcinoma. J Hepatol (2010) 0.95
Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg (2005) 0.95
Pancreas divisum: a study of the cadaveric donor pancreas for islet isolation. Pancreas (2005) 0.94
Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation (2002) 0.93
Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis. Transplantation (2006) 0.93
Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts. J Cell Physiol (2007) 0.93
Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort study. Crit Care (2013) 0.93
Mice with chimeric human livers: who says supermodels have to be tall? Hepatology (2005) 0.92
Changes in liver enzymes after clinical islet transplantation. Transplantation (2003) 0.92
Quantifying macrophage defects in type 1 diabetes. J Theor Biol (2005) 0.92
Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts. Xenotransplantation (2006) 0.92
ABO-incompatible liver transplantation for critically ill adult patients. Transpl Int (2007) 0.91
Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice. Cell Transplant (2008) 0.90
Detection of microbial contamination during human islet isolation. Cell Transplant (2007) 0.90
Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. Eur J Cardiothorac Surg (2005) 0.90
Clinical islet transplant: current and future directions towards tolerance. Immunol Rev (2003) 0.90
Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation (2004) 0.90